( July 10, 2026, 8:00 AM EDT) -- BOSTON — A federal judge in Massachusetts dismissed an investor’s putative securities class action against a biotechnology company, certain officers and directors, as well as the underwriters of its initial public offering (IPO) for allegedly omitting information from the company’s registration statement in violation of federal securities laws, finding that the investor did not plausibly identify an unlawful omission....